When to use apremilast and biologics and how to deal with vascular involvement were some of the main areas to be updated in ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Different vasoactive vasodilating drugs were associated with protective effects depending on patients' vasculopathy, but ...